Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase I study is to determine the safety and effectiveness of two
chemotherapies drugs, Cetuximab and Pemetrexed (Alimta), when given in combination with
radiation therapy.